RT Journal Article SR Electronic T1 Integrating palliative care into neurology services: what do the professionals say? JF BMJ Supportive & Palliative Care JO BMJ Support Palliat Care FD British Medical Journal Publishing Group SP bmjspcare-2017-001354 DO 10.1136/bmjspcare-2017-001354 A1 Nilay Hepgul A1 Wei Gao A1 Catherine J Evans A1 Diana Jackson A1 Liesbeth M van Vliet A1 Anthony Byrne A1 Vincent Crosby A1 Karen E Groves A1 Fiona Lindsay A1 Irene J Higginson A1 , YR 2017 UL http://spcare.bmj.com/content/early/2017/08/03/bmjspcare-2017-001354.abstract AB Objectives Evaluations of new services for palliative care in non-cancer conditions are few. OPTCARE Neuro is a multicentre trial evaluating the effectiveness of short-term integrated palliative care (SIPC) for progressive long-term neurological conditions. Here, we present survey results describing the current levels of collaboration between neurology and palliative care services and exploring the views of professionals towards the new SIPC service.Methods Neurology and palliative care teams from six UK trial sites (London, Nottingham, Liverpool, Cardiff, Brighton and Chertsey) were approached via email to complete an online survey. The survey was launched in July 2015 and consisted of multiple choice or open comment questions with responses collected using online forms.Results 33 neurology and 26 palliative care professionals responded. Collaborations between the two specialties were reported as being ‘good/excellent’ by 36% of neurology and by 58% of palliative care professionals. However, nearly half (45%) of neurology compared with only 12% of palliative care professionals rated current levels as being ‘poor/none’. Both professional groups felt that the new SIPC service would influence future collaborations for the better. However, they identified a number of barriers for the new SIPC service such as resources and clinician awareness.Conclusions Our results demonstrate the opportunity to increase collaboration between neurology and palliative care services for people with progressive neurological conditions, and the acceptability of SIPC as a model to support this.Trial registration number ISRCTN18337380; Pre-results.